Skip to content

house · Committee report

H. Rept. 119-742

MEASURING ILLICIT FENTANYL TRAFFICKING ACT

2026-07-13

Committees

Associated legislation

Text

Purpose and Summary

H.R. 8535, the ``Measuring Illicit Fentanyl Trafficking Act,'' would require the Secretary of Homeland Security to develop performance metrics relating to the detection, deterrence, and seizure of illicit fentanyl for the Department of Homeland Security and each of its components. As illicit fentanyl is the leading cause of overdose deaths in the United States, this legislation would seek to bolster data sharing across the Department and eliminate siloing of information that could impair the Department's effectiveness in countering this threat.

Background and Need for Legislation

Fentanyl deaths are the leading cause of overdose deaths in the United States, killing tens of thousands of people, and the leading cause of death overall for those ages 18-45. Nearly all the precursors, or key ingredients, of illicit fentanyl are produced in China and then shipped to Mexico where illicit fentanyl is manufactured and smuggled into the United States. Frontline officers and agents within the Department of Homeland Security (DHS), specifically, U.S. Customs and Border Protection (CBP) and Homeland Security Investigations (HSI) within U.S. Immigration and Customs Enforcement (ICE), are the entities primarily charged with detecting and seizing illicit fentanyl. From Fiscal Year (FY) 2021 through FY 2024, CBP and ICE led or assisted on the seizure of nearly 460,000 pounds of fentanyl and fentanyl precursors. While CBP and ICE are seizing fentanyl and fentanyl precursors, DHS does not consider overdose death numbers, drug street pricing, or other factors that could indicate the volume at which fentanyl is still entering the country. In an effort to address this problem, the James M. Inhofe National Defense Authorization Act (NDAA) for Fiscal Year 2023 (P.L. 117-263) required DHS to establish a program that would collect data and develop measures to assess the effectiveness of efforts to detect and deter illicit fentanyl. It also required the Government Accountability Office (GAO) to conduct an audit of the program. In September 2025, the Government Accountability Office (GAO) released their report evaluating DHS's implementation of the program, as required by the FY 2023 NDAA. The report found that DHS had not established the program as required by the Act, that CBP was not provided information from across the Department that would inform the program, and that DHS had not developed performance goals or metrics to assess the program's effectiveness. This legislation would build on the efforts of the FY 2023 NDAA by requiring the Secretary of Homeland Security to develop performance metrics relating to the detection, deterrence, and seizure of illicit fentanyl, and to require each relevant component of DHS to share information between components and identify any barriers that would prevent the sharing of this data. The legislation requires this to take place within one year of enactment.

Hearings

The Committee held the following hearings in the 119th Congress that informed H.R. 8535: On March 5, 2025, the Committee on Homeland Security held a hearing entitled ``Countering Threats Posed by the Chinese Communist Party to U.S. National Security.'' Members received testimony from Dr. Rush Doshi, Assistant Professor of Security Studies at the Georgetown University Walsh School of Foreign Service and C.V. Starr Senior Fellow for Asia Studies and Director of the China Strategy Initiative at the Council on Foreign Relations. In his testimony, Mr. Doshi highlighted the role of the Chinese Communist Party in subsidizing the manufacturing of fentanyl precursors and aiding cartels in trafficking deadly fentanyl into the United States. On January 22, 2026, the Subcommittee on Border Security and Enforcement held a hearing entitled, ``Smarter Borders, Safer Nation: Expanding the Use of Non-Intrusive Inspection Technology.'' Members received testimony from Diane J. Sabatino, Acting Executive Assistant Commissioner, Office of Field Operations, U.S. Customs and Border Protection, U.S. Department of Homeland Security. Ms. Sabatino testified to the importance of non-intrusive inspection technology in seizing illicit drugs, including fentanyl.

Committee Consideration

The Committee met on June 24, 2026, a quorum being present, to consider H.R. 8535 and ordered the measure to be favorably reported to the House, as amended, by a recorded vote of 30 yeas to 0 nays.

Committee Votes

Clause 3(b) of rule XIII requires the Committee to list the recorded votes on the motion to report legislation and the amendments thereto. The following reflects the recorded votes taken during the Committee consideration: [GRAPHIC(S) NOT AVAILABLE IN TIFF FORMAT] COMMITTEE OVERSIGHT FINDINGS In compliance with clause 3(c)(1) of rule XIII, the Committee advises that the findings and recommendations of the Committee, based on oversight activities under clause 2(b)(1) of rule X, are incorporated in the descriptive portions of this report. CONGRESSIONAL BUDGET OFFICE ESTIMATE, NEW BUDGET AUTHORITY, ENTITLEMENT AUTHORITY, AND TAX EXPENDITURES With respect to the requirements of clause 3(c)(2) of rule XIII and section 308(a) of the Congressional Budget Act of 1974, and with respect to the requirements of clause 3(c)(3) of rule XIII and section 402 of the Congressional Budget Act of 1974, the Committee has requested but not received from the Director of the Congressional Budget Office a statement as to whether this bill contains any new budget authority, spending authority, credit authority, or an increase or decrease in revenues or tax expenditures. FEDERAL MANDATES STATEMENT An estimate of Federal mandates prepared by the Director of the Congressional Budget Office pursuant to section 423 of the Unfunded Mandates Reform Act was not made available to the Committee in time for the filing of this report. The Chairman of the Committee shall cause such estimate to be printed in the Congressional Record upon its receipt by the Committee. DUPLICATIVE FEDERAL PROGRAMS Pursuant to clause 3(c) of rule XIII, the Committee finds that H.R. 8535 does not contain any provision that establishes or reauthorizes a program known to be duplicative of another Federal program. STATEMENT OF GENERAL PERFORMANCE GOALS AND OBJECTIVES Pursuant to clause 3(c)(4) of rule XIII, the objective of H.R. 8535 is to require the Secretary of Homeland Security to develop performance metrics relating to the detection, deterrence, and seizure of illicit fentanyl for the Department of Homeland Security and its components. The bill also requires each relevant component of the Department to share information related to the detection, deterrence, and seizure of illicit fentanyl and identify any barrier related to the sharing of this information and data. CONGRESSIONAL EARMARKS, LIMITED TAX BENEFITS, AND LIMITED TARIFF BENEFITS In compliance with rule XXI, this bill, as reported, contains no congressional earmarks, limited tax benefits, or limited tariff benefits as defined in clause 9(d), 9(e), or 9(f) of rule XXI. ADVISORY COMMITTEE STATEMENT No advisory committees within the meaning of section 5(b) of the Federal Advisory Committee Act were created by this legislation. APPLICABILITY TO THE LEGISLATIVE BRANCH The Committee finds that H.R. 8535 does not relate to the terms and conditions of employment or access to public services or accommodations within the meaning of section 102(b)(3) of the Congressional Accountability Act. SECTION-BY-SECTION ANALYSIS OF THE LEGISLATION Section 1. Short title This section states that the Act may be cited as the ``Measuring Illicit Fentanyl Trafficking Act.'' Section 2. Combatting illicit fentanyl This section requires the Secretary of Homeland Security, not later than one year after the date of enactment of this legislation, to ensure that each component of DHS which is engaged in the detection, deterrence, and seizure of illicit fentanyl, collaborate and share, to the extent practicable, information and data regarding the detection, deterrence, and seizure of illicit fentanyl with other DHS components engaged in these activities. It also requires each DHS component engaged in combatting illicit fentanyl trafficking to identify any barriers to sharing the relevant information and data. This section also requires the Secretary to develop performance measures relating to the detection, deterrence, and seizure of illicit fentanyl for DHS and each DHS component, and ensure that the metrics align with the strategic goals of the Department as it relates to combatting illicit fentanyl trafficking. [all]

Source: https://api.congress.gov/v3/committee-report/119/hrpt/742